Significados de biological therapy en inglés

We review the recent advances in biological therapy for UC treatment beyond the anti-TNFs.

Multivariate analysis indicated that biological therapy and Cohort B were associated with improved mOS.

Esophageal squamous cell carcinoma is one of the most chemo- and biological therapy resistant cancers.

Lower economic profile and never reading books were both associated with decreased odds of receiving biological therapy.

They also cover the topical treatment of psoriasis, photo(chemo)therapy, conventional systemic therapy and biological therapy.

Results: After 1 year, 35% of the patients were on biological therapy.

Conclusions: We present an update of the SER recommendations for the use of biological therapy in patients with axSpA.

Our analysis showed that all analyzed patients' characteristics were significantly associated with biological therapy compared to non-biological systemic one.

Background Randomized controlled trials evaluating biological therapy have shown improvements in survival from metastatic colorectal cancer (mCRC).

The biological therapy of Crohn's disease, such as infliximab is a powerful approach in the therapy of inflammatory bowel diseases.

NY-ESO-1 or survivin expression in glioma represents viable targets for anticancer-directed T-cells for the biological therapy of patients with glioma.

Active research into biological therapy is also under way and vaccines, antibodies and inhibitors of growth factors are all being evaluated.

Surgery is not often used as a treatment because of the efficacy of chemotherapy, biological therapy, radiotherapy and hematopoietic stem cell transplantation.

In this new era of biological therapy, medications that precisely target the molecular mediators of inflammation are being developed at a rapid pace.

The Ulster team has developed the world's first biological therapy to target NLRP3 and proof of concept tests have shown it exhibits superior anti-inflammatory activity.

Finally, we drafted some recommendations for the treatment of patients refractory to anti-tumor necrosis factor, as well as for the possible optimization of biological therapy.